XGN Exagen Inc.
Healthcare$4.28+0.00%OpenMarket Cap: $103.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
7.04
P/S
1.51
EV/EBITDA
-5.42
DCF Value
$-12.12
FCF Yield
-13.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
58.3%
Operating Margin
-20.6%
Net Margin
-29.5%
ROE
-113.5%
ROA
-38.8%
ROIC
-33.3%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $17.3M | 59.0% | $-3.4M | $-4.0M | $— | — |
| Q4 null | $16.6M | 55.4% | $-5.0M | $-4.7M | $— | — |
| FY null | $66.6M | 58.3% | $-14.1M | $-20.0M | $— | — |
| Q3 null | $17.2M | 58.4% | $-3.1M | $-7.1M | $— | — |
| Q2 null | $17.2M | 60.4% | $-2.6M | $-4.4M | $— | — |
| Q1 null | $15.5M | 58.9% | $-3.4M | $-3.8M | $— | — |
| Q4 null | $13.7M | 62.1% | $-3.4M | $-3.8M | $— | — |
| FY null | $55.6M | 59.5% | $-13.6M | $-15.1M | $— | — |
| Q3 null | $12.5M | 55.8% | $-4.7M | $-5.0M | $— | — |
| Q2 null | $15.1M | 60.1% | $-2.6M | $-3.0M | $— | — |
| Q1 null | $14.4M | 59.6% | $-3.0M | $-3.4M | $— | — |
| Q4 2023 | $13.8M | 59.2% | $-5.1M | $-5.6M | $-0.31 | — |